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A staphylococcal surface protein capable of binding several extracellular matrix glycoproteins was purified
as a result of our attempts to identify a receptor(s) for bone sialoprotein (BSP) on Staphylococcus aureus cells.
Proteins from different staphylococcal strains were solubilized in sodium lauryl sulfate, separated by
polyacrylamide gel electrophoresis, blotted onto Immobilon P membranes, and probed with 1251-BSP. Several
bacterial proteins bound the radiolabeled ligand, and various strains expressed different repertoirs of
BSP-binding proteins. Major BSP-binding proteins with apparent Mrs of 72,000 or 60,000 were present on
most strains, and these proteins were further studied. The 72- and 60-kDa proteins were preferentially
expressed when bacteria were cultured in Luria broth compared with when they were cultured on tryptic soy
broth, and the abundance of the proteins could be correlated to an increased 125I-BSP binding. Both the 72-kDa
and the 60-kDa proteins were solubilized by extraction of cells with 1 M LiCl and were purified by
cation-exchange chromatography. Amino acid composition analysis of the purified 72-kDa protein indicated a
high content of lysine (11.9%) and hydrophobic amino acids (28.0%o combined). In Western ligand blotting
(immunoblotting) experiments, the 72-kDa protein bound not only BSP but also radiolabeled fibronectin,
fibrinogen, vitronectin, thrombospondin, and, to some extent, collagen. Addition of the purified 60-kDa protein
to S. aureus cells did not inhibit binding of the different ligands but in some cases resulted in an augmentation
of the binding of 1251-ligand. Purified 60-kDa protein could hemagglutinate sheep erythrocytes at a
concentration of 61 pg/ml. The agglutination reaction was inhibited by high concentrations of fucose, mannose,
or melibiose. These data suggest that the purified proteins may serve as bacterial receptors with broad
specificity for matrix glycoproteins and that the proteins may act as carbohydrate-binding proteins.
Staphylococcus aureus is a major human pathogen and is
associated with infections such as bacterial arthritis (5),
osteomyelitis (28, 37), and acute infectious endocarditis (25).
Staphylococci can also cause pneumonia and tracheobron-
chitis in immunocompromised patients and patients with
cystic fibrosis (26).
The initial step in an infectious disease is often the
adhesion and colonization of host tissue surfaces. A number
of bacterial cell surface structures have been identified as
mediators of host tissue adherence. Previous studies of
gram-negative bacteria indicated that adhesion of these
bacteria to tissues is mediated primarily through lectins
present on pili or fimbriae (12, 20). These lectins recognize
and bind to glycoproteins and glycolipids present on host cell
surfaces. Gram-positive bacteria, on the other hand, appear
to adhere primarily to extracellular matrix molecules such as
fibronectin (FN) via specific cell surface receptors in what
are believed to be protein-protein interactions. Also, some
gram-negative bacteria can recognize and bind to extracel-
lular matrix proteins (reviewed in reference 10).
The S. aureus FN receptor is probably the best-character-
ized bacterial receptor for an extracellular matrix protein (4,
13, 18, 31). Two very similar and closely spaced staphylo-
coccal genes coding for FN-binding proteins have been
* Corresponding author.
t Present address: Institute of Microbiology and Immunology
University of "di, ul.Banacha 12/16, Poland.
identified (13). The FN-binding activity is located to a
segment composed of a 38-amino-acid motif which is re-
peated three times in both proteins (13, 18, 31). The receptor
binds to the N-terminal domain of FN, which is not known to
contain any carbohydrate. Binding of FN to staphylococcal
cells therefore appears to involve primarily a protein-protein
interaction. Staphylococcal cells may also express receptors
for thrombospondin (TSP), bone sialoprotein (BSP), fibrin-
ogen (FBG), collagen, and vitronectin (VN) (1, 7-10, 30, 33,
35). Expression of receptors for matrix proteins with specific
tissue distribution may partly explain the tissue tropism of
infections caused by various staphylococcal strains. Thus,
staphylococcal strains isolated from patients with septic
arthritis express a collagen receptor, and the presence of this
receptor appears to be necessary and sufficient for bacteria
to adhere to cartilage (34). Osteomyelitis- derived strains
also had a high binding capacity for BSP which was on
average five times higher than that expressed by strains
isolated from patients with endocarditis (29).
In the present study, we screened several S. aureus
isolates from different sources for the presence of bacterial
proteins capable of binding BSP. BSP is a glycoprotein
found only in the bone matrix and dentin (3), and the ability
to bind BSP may be a factor which targets S. aureus cells to
bone tissue (28-30). The data presented here describe a
72-kDa protein and a 60-kDa protein which have BSP-
binding activity and are present on many strains. These
proteins, which are released from bacterial cells by treat-
ment with 1 M LiCl and purified by cation-exchange chro-
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matography, bind not only BSP but also FN, TSP, VN, and
FBG. Furthermore, the 60-kDa protein can agglutinate
sheep erythrocytes (SRBC) possibly via a lectin-like activ-
ity, which may account for its ability to bind a number of
matrix glycoproteins. Hence, the 72- and 60-kDa proteins
may represent a general adhesin mediating or augmenting
staphylococcal adherence to a variety of extracellular matri-
ces.
MATERIALS AND METHODS
Bacteria and growth conditions. The S. aureus clinical
isolates were from the Department of Orthopedics, Bowman
Gray School of Medicine, Winston-Salem, N.C., or the
Clinical Pathology Laboratory, School of Medicine, Univer-
sity of Alabama at Birmingham, Birmingham (34). These
isolates include X50151, 87/8, and 87/12 from synovial fluid;
F44947 isolated from sputum; M65051 isolated from a soft
tissue infection; strain Cowan (33) isolated from a septic
arthritis patient; and 88/4, an osteomyelitis isolate. Strain
024, an osteomyelitis isolate, has been described previously
(30). Strain Newman (4) was obtained from the Department
of Bacteriology, College of Veterinary Medicine, Uppsala,
Sweden, and S. aureus #574 was obtained from the U.S.
Food and Drug Administration.
Glycerol stocks were made from overnight cultures in
tryptic soy broth (TSB; Difco, Detroit, Mich.) and were
stored at -20°C. S. aureus cultures were started by inocu-
lation from glycerol stocks into either TSB or Luria broth
(LB; GIBCO BRL). After overnight growth at 37°C with
agitation, cells were harvested by centrifugation (3,600 x g,
15 min) and resuspended in phosphate-buffered saline (PBS:
10 mM phosphate, 0.14 M NaCl, 0.02% sodium azide, pH
7.4). Cell density was adjusted to 8 x 109 cells per ml by
using a reference standard curve relating optical density at
600 nm to cell number. The cells were kept on ice until used.
Preparation and iodination of ligands. The ligands used for
this study were obtained from the following sources. BSP,
isolated from a rat osteogenic cell line (19), was a gift from L.
Fisher of the National Institutes of Health, Bethesda, Md.
Collagen type II isolated from chicken sternum (27) was
provided by R. Mayne, Department of Cell Biology, Univer-
sity of Alabama at Birmingham. FN and the 29-kDa N-ter-
minal FN fragment were isolated from porcine plasma as
described elsewhere (2). Human FBG was obtained from
KabiVitrum, Stockholm, Sweden, and further purified by
passage through gelatin-Sepharose to remove contaminating
FN (16). TSP purified from fresh human platelets (22) was
provided by J. Murphy-Ullrich, Department of Pathology,
University of Alabama at Birmingham. Human VN was
purchased from Sigma Chemical Co. (St. Louis, Mo.) or
Collaborative Biomedical Products (Bedford, Mass.).
Iodination of ligands was conducted by either the chlo-
ramine T method of Hunter (11) or the lactoperoxidase
method (21) using Enzymobeads (Bio-Rad Corp, Richmond,
Calif.). The estimated specific activities of the iodinated
ligands ranged from 2.0 x 106 to 4.4 x 107 cpm/,Lg.
Binding of ligands to bacteria. The binding of radiolabeled
ligands to bacterial cells was quantitated essentially as
described by Froman et al. (4). Tubes (75 by 12 mm, 4.5 ml;
Sarstedt, Newton, N.C.) were precoated with 5% (wt/vol)
bovine serum albumin (BSA; Sigma) in PBS on an end-over-
end mixer for a minimum of 1 h to reduce nonspecific binding
to the plastic surface. The binding buffer used was either
0.1% (wt/vol) BSA in PBS containing 0.1% Tween 80 (ligand
binding buffer I) or 10 mM HEPES (N-2-hydroxyethylpiper-
azine-N'-2-ethanesulfonic acid), pH 7.4, containing 137 mM
NaCl, 5 mM KCl, 0.7 mM MgSO4, 1.2 mM CaCl2, and 0.1%
BSA (ligand binding buffer II [24]). In either case, 8 x 108
cells were added to 5 x 104 cpm of 125I-labeled ligand in a
final volume of 0.5 ml of binding buffer. Tubes containing the
incubation samples were rotated end over end at room
temperature for 90 min. The reaction was stopped by the
addition of 3 ml of ice-cold PBS containing 0.1% Tween 80
(PBS-Tween), followed by centrifugation. The supernatant
was aspirated, and the radioactivity associated with the
bacterial cell pellet was quantitated in a gamma counter
(LKB, Turku, Finland). Some binding assays were con-
ducted in the presence of 10 mM EDTA or 0.2 M mannose.
Solubilization of S. aureus proteins. (i) Solubilization in SDS.
Overnight cultures of S. aureus cells were harvested by
centrifugation, and bacteria were suspended in PBS to 1/10 of
the original volume. All cell suspensions were adjusted by
addition of PBS to the same optical density at 600 nm. The
cells were boiled in the presence of 2% sodium dodecyl
sulfate (SDS) and 5% 2-mercaptoethanol for 3 min and loaded
onto SDS-polyacrylamide gel electrophoresis (PAGE) gels.
(ii) Lysostaphin digestion. To solubilize S. aureus cell
surface proteins, cells were digested with lysostaphin (Sig-
ma) as previously described (4). The residual cells were
removed by centrifugation. The solubilized surface proteins
recovered in the supernatant were further analyzed.
(iii) Trypsin digestion. Overnight cultures of S. aureus cells
were harvested by centrifugation (3,600 x g, 15 min) and
resuspended in 1/10 volume of PBS and adjusted to the same
optical density at 600 nm. The cells were incubated with 25
p,g of trypsin (Sigma) per ml for 1 h at 37°C. The reaction was
stopped by adding 50 ,ug of soybean trypsin inhibitor (Sigma)
per ml as described elsewhere (32). The residual cells were
collected by centrifugation and used in binding assays.
(iv) Lithium chloride extraction. Overnight bacterial cul-
tures were harvested by centrifugation (3,600 x g, 15 min)
and resuspended in 1/10 volume of 1 M LiCl, pH 6.0. The
cell suspension was incubated at 45°C for 2 h with gentle
agitation. Subsequently, the cells were removed by centrif-
ugation (3,600 x g, 15 min), and the supernatant containing
solubilized proteins was collected.
Detection of ligand-binding components by Western ligand
blotting (immunoblotting). Proteins were separated by SDS-
PAGE using gradient gels of 3 to 15% acrylamide and the
buffer system of Laemmli (15). Proteins were transferred to
Immobilon P (Millipore, Bedford, Mass.) membranes with
the Bio-Rad Trans-Blot apparatus and the transfer buffer of
Towbin et al. (36). Additional protein-binding sites on the
membranes were blocked by incubation for 60 min in PBS
containing 3% (wt/vol) BSA. Membranes were then incu-
bated overnight at 4°C with gentle agitation in a solution
containing 105 cpm of 125I-labeled ligand in ligand binding
buffer I. Subsequently, the membranes were washed exten-
sively with 0.1% Tween 20 in PBS, air dried, and exposed to
Fuji RX-100 X-ray film for 4 to 16 h at 4°C.
Purification of ligand-binding components. Protein was
precipitated from the LiCl extracts of S. aureus cells cul-
tured in LB by the addition of ammonium sulfate to a final
concentration of 60% (wt/vol), followed by gentle stirring
overnight at 4°C. The precipitated protein was recovered by
centrifugation (15,000 x g, 30 min), and the pellet was
resuspended in a minimal volume of 10 mM Tris-HCl, pH
7.5. In preparation of further purification steps, protein was
dialyzed against three changes of 10 mM Tris-HCl (pH 7.5)
buffer at 4°C.
The dialyzed protein solution was clarified by centrifuga-
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tion and subjected to cation-exchange chromatography on a
Mono-S column (Pharmacia, Uppsala, Sweden) fitted on a
Pharmacia FPLC system. The column was equilibrated in 10
mM Tris-HCl, pH 7.5, and bound protein was eluted with a
linear gradient of up to 1 M NaCl in 10 mM Tris-HCl, pH 7.5.
The eluate was monitored by measuring the A280, and
protein-containing fractions were analyzed by SDS-PAGE.
Ligand-binding components were detected by Western li-
gand blotting. Peak fractions containing ligand-binding ac-
tivity were pooled and stored at -20°C.
Hemagglutination of SRBC with purified protein. The hem-
agglutination titration was conducted as previously de-
scribed for the Sophora japonica lectin (20). Serial twofold
dilutions of a 1-mg/ml stock solution of purified protein were
made with PBS as the diluent in a microtiter plate. The final
volume of the diluted protein was 100 ,ul. An equal volume of
a 2% suspension of SRBC (Colorado Serum Co., Denver)
was added to the protein dilutions. After incubation at room
temperature for 1 h, the agglutination was scored. The
microtiter round-bottom well containing no protein resulted
in the SRBC forming a button, whereas agglutination results
in a mat of SRBC on the bottom of the microtiter well. The
titer was defined as the lowest dilution which caused agglu-
tination of the erythrocytes. Inhibition of hemagglutination
was tested by addition of serial twofold dilutions of the
following carbohydrates: 0.1 M lactose, 0.1 M mannose, 0.1
M melibiose, 0.05 M L-fucose, 0.1 M N-acetyl-D-glu-
cosamine, and 0.05 M N-acetyl-D-galactosamine (E-Y Lab-
oratories Inc., San Mateo, Calif.) in PBS.
Amino acid composition analysis of purified protein. Puri-
fied protein was analyzed for amino acid composition by the
Protein Chemistry Core Facility of the University of Ala-
bama at Birmingham Cancer Center on an Applied Biosys-
tems 420A derivatizer, 130A separation system, and 920A
data analysis module.
RESULTS
Several S. aureus proteins bind BSP. Initial characteriza-
tion of the binding of BSP to S. aureus Newman and #574
indicated that the amounts of radiolabeled ligand bound to
the bacterial cells were not, in our hands, affected by the
presence of 1.2 mM CaCl2, 0.7 mM MgSO4, and 10 mM
EDTA in the binding buffer as reported in other studies (30).
The growth media used to culture bacteria affected the
BSP-binding capacity, particularly that of strain #574. When
grown in LB, cells of strain #574 bound as much as 50%
more freshly labeled BSP than did cells cultured in TSB.
Strain Newman bound larger amounts of 125I-BSP than did
strain #574, and the BSP-binding capacity of the former
strain was less affected by the growth media used. Treatment
of bacterial cells with trypsin and/or lysostaphin resulted in
a 50% reduction of the amount of ligand bound, suggesting
that bacterial surface proteins are at least partially respon-
sible for the binding of 125I-BSP.
To assess whether the interaction of BSP with the bacte-
rial cells is mediated by specific protein components, whole-
cell lysates of the various S. aureus strains were separated
b SDS-PAGE and subjected to Western ligand blotting with
15I-BSP (Fig. 1). The repertoire of BSP-binding proteins
varied among different strains. All strains analyzed con-
tained a BSP-binding protein of approximately 32 kDa and
two smaller BSP-binding proteins of approximately 18 and
14 kDa. The largest protein species which bound BSP was
approximately 85 kDa and is prevalent in strains F44947,
87/2, #574, and 024. A 72-kDa BSP-binding protein was
1 2 3 4 5 6 7 8 9 10 11
97
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31-
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FIG. 1. Autoradiogram of Western ligand blotting of S. aureus
strains with '25I-BSP. Proteins in lysates of S. aureus cells cultured
in TSB were separated by SDS-PAGE on 3 to 15% acrylamide gels
and transferred to an Immobilon P membrane. Additional protein-
binding sites on the membrane were blocked by incubation in a
solution of PBS containing 3% (wt/vol) BSA for 60 min. The
membrane was then incubated overnight at 4°C in 105 cpm of
'"I-BSP in ligand binding buffer I. The membrane was washed in
PBS-Tween 20, air dried, and exposed to Fuji RX-100 X-ray film
overnight. Lane 1, low-molecular-weight markers (Bio-Rad) (indi-
cated on the left in thousands). The S. aureus isolates are in the
remaining lanes as follows: lane 2, X50151; lane 3, F44947; lane 4,
87/8; lane 5, 87/12; lane 6, #574, lane 7, 024; lane 8, Cowan; lane 9,
M65051; lane 10, Newman; and lane 11, 88/4.
observed in strains X50151, 87/8, 87/2, #574, Cowan, and
88/4. A 60-kDa BSP-binding protein was predominant in
strain Newman and also observed in strains Cowan,
M65051, and 88/4.
Solubilization and purification of BSP-binding proteins
from S. aureus. Cells of strain #574 were grown overnight in
LB and TSB and boiled in SDS, and solubilized proteins
were separated by SDS-PAGE. The results of these experi-
ments showed that two major proteins with Mrs of 72,000
and 60,000 are preferentially expressed by cells grown in LB
(Fig. 2A, lanes 2 and 5). Western ligand blotting showed that
the two proteins are major BSP-binding proteins (Fig. 2B,
lane 2). Our studies were therefore focused on attempts to
isolate and characterize these proteins. Extraction of cells
with 1 M LiCl resulted in the preferential solubilization of
the 72-kDa protein from cells grown in LB or TSB (Fig. 2A),
and Western ligand blotting showed that this protein bound
15I-BSP. The LiCl extract of cells grown in LB also con-
tained three additional BSP-binding proteins with apparent
molecular masses of 180, 140, and 60 kDa.
Since LiCl apparently solubilized the major BSP-binding
proteins from strain #574, this extraction method was also
used to solubilize protein from strain Newman cultured in
LB. Solubilized proteins were recovered by ammonium
sulfate precipitation and fractionated on a Mono-S cation-
exchange column fitted on an FPLC system. The column
was eluted with a NaCl gradient, and the protein concentra-
tions of the eluted fractions were estimated by analyzing the
A280. The two major peaks of protein eluted between 0.7 and
0.8 M NaCl and were found to each contain an apparently
homogenous 60-kDa protein. The purified protein was sub-
ject to amino acid composition analysis (Table 1) which
revealed a high molar percentage of lysine (11.9%), aspar-
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FIG. 2. SDS-PAGE and Western ligand blots of S. aureus #574 cellular extracts after growth in TSB or LB. Gel electrophoresis (A) and
Western ligand blotting (B) were conducted as outlined in Materials and Methods and the legend to Fig. 1. Lanes 1 contain prestained
molecular weight standards (Bio-Rad) (indicated on the left in thousands). Samples in lanes 2, 3, and 4 are from S. aureus cultured in LB,
and those in lanes 5, 6, and 7 are from cells cultured in TSB. Lanes 2 and 5, S. aureus cells solubilized in SDS; lanes 3 and 6, LiCl-released
proteins; lanes 4 and 7, the protein in S. aureus cell residues after LiCl extraction. (A) Gel stained with Coomassie blue; (B) autoradiogram
after 1251-BSP binding.
agine-aspartic acid (combined: 16.9%), and hydrophobic
amino acids (28.0%).
The 72-kDa protein was purified from the Food and Drug
Administration strain #574 grown in LB by the same puri-
fication protocol as described above for the purification of
the 60-kDa protein from strain Newman. The purified pro-
teins were checked for binding activity by the Western
ligand blot assay. The purified 60-kDa protein from strain
Newman and the purified 72-kDa protein from strain #574
both bound 125I-BSP, as demonstrated by Western ligand
blotting (Fig. 3). The relationship between the isolated
60-kDa protein from S. aureus Newman and the 72-kDa
protein from S. aureus #574 is presently unclear.
The purified proteins are general binders of extracellular
matrix glycoproteins. The ligand binding specificity of the
72-kDa protein purified from strain #574 was further ana-
lyzed. Various radiolabeled matrix glycoproteins, including
FN, FBG, collagen, VN, and TSP, were used to probe
Western blots of whole S. aureus #574 cells, LiCl extracts,
and the extracted residues of cells grown in both LB and
TSP. Remarkably similar patterns (Fig. 4) were obtained
regardless of which ligand was used to probe the mem-
branes, although the intensity on the autoradiogram varied
considerably. The binding of ligands such as VN and TSP
was more dramatic than that of collagen. The two higher-
molecular-weight proteins in the LiCl extracts which bound
BSP (Fig. 2) also appear to bind both 125I-labeled VN and
TSP. There is more ligand binding associated with the
samples prepared from cells cultured in LB, and the major
ligand-binding protein has an Mr of 72,000 and is solubilized
by extraction of bacteria with 1 M LiCl. Taken together,
these data suggest that the same bacterial protein is capable
of binding all the different ligands tested. When the purified
TABLE 1. Amino acid composition of the 60-kDa protein
purified from S. aureus Newman
Amino acid mol%a
Asparagine-aspartic acid................. 16.9
Glutamine-glutamic acid................. 6.8
Serine................. 10.3
Glycine................. 5.1
Histidine ................. 1.5
Arginine................. 3.3
Threonine................. 7.7
Alanine................. 4.8
Proline................. 2.2
Tyrosine................. 6.0
Valine................. 6.0
Methionine ................. ND
Cysteine................. ND
Isoleucine................. 7.3
Leucine................. 7.5
Phenylalanine................. 2.4
Lysine ................. 11.9
Tryptophan................. ND
a ND, not determined.
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FIG. 3. Gel electrophoresis and Western ligand blot with 125I-
BSP of purified proteins from S. aureus Newman and #574. (A)
SDS-PAGE of proteins purified by FPLC. The gel is stained with
Coomassie blue. (B) Western ligand blotting with 125I-BSP of the
same preparations. Lanes 1, high-molecular-weight (A) and pre-
stained molecular weight (B) markers (indicated on the left in
thousands). Lanes 2 and 3, the two major protein peaks from FPLC
of LiCl-extracted material from strain Newman; lane 4, protein
isolated from S. aureus #574.
INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
S. AUREUS EXTRACELLULAR MATRIX-BINDING PROTEIN 2483
A
1 2 3 4 5 6 7
B
1 2 3 4 5 6 7 1 2
C
3 4 5 6 7
D
2 3 4 5 6
200 . . ..-
E
7 1 2 3 4 5 f
..1
..
':
97
68
43
25 I1 ..
FIG. 4. Binding of 1"I-ligands to S. aureus #574 cellular protein extracts after culture in TSB or LB. S. aureus cells grown in TSB or LB
were extracted and subjected to Western ligand blotting as described in Materials and Methods and the legend to Fig. 1. Lanes were as
described in the legend to Fig. 2. Ligands were as follows: '25I-FN (A), 125I-FBG (B), "I51-collagen (C), 'TI-VN (D), and 125I-TSP (E).
60-kDa protein from strain Newman and the 72-kDa protein
from #574 were tested, both proteins bound all radiolabeled
ligands, demonstrating a broad binding specificity for these
proteins (data not shown). It is noteworthy that the 210-kDa
FN (4, 31) or the 135-kDa collagen (24, 35) receptors could
not be detected in Western ligand blots.
If the purified proteins represent soluble formns of the
primary receptor for each of the ligands tested, then the
isolated proteins would be expected to competitively inhibit
ligand binding to intact bacteria. Binding assays in which
increasing amounts of 60-kDa protein purified from strain
Newman were added to incubation mixtures containing S.
aureus cells and different radiolabeled ligands were therefore
conducted. The results of these experiments show (Fig. 5)
that in the case of the 29-kDa FN fragment, there was a slight
decrease in the amount of iodinated ligand bound to bacterial
cells when purified 60-kDa protein was added. For all of the
other ligands assayed, enhancement of ligand binding to the
bacterial cells was observed with increasing amounts of
60-kDa protein added. The binding of TSP and that of VN
were increased up to 13- and 15-fold, respectively, over the
amount of radiolabeled ligand bound in the absence of added
60-kDa protein. The observed maximal enhancement of
collagen, BSP, FN, and FBG binding, was 1.2-, 1.5-, 2.8-,
and 4.3-fold, respectively, above the level observed with no
addition of 60-kDa protein. The extent of ligand binding
enhancement caused by addition of the 60-kDa protein
varied from one experiment to another, and the molecular
basis for this effect remains unclear.
The isolated 60-kDa protein is an agglutinin. The ability of
the purified proteins to bind several nonrelated extracellular
matrix glycoproteins suggested that this protein may act as a
lectin. The protein was therefore tested for the ability to
hemagglutinate SRBC. The results of these experiments
showed that the 60-kDa protein at concentrations of 61 ,ug/ml
and higher agglutinated the SRBC (data not shown). This
interaction could be inhibited by the addition of L-fucose
(0.0125 M), D-mannose (0.05 M), and melibiose (0.025 M)
but was not affected by lactose (0.1 M), N-acetyl-D-glu-
cosamine (0.1 M), or N-acetyl-D-galactosamine (0.05 M).
Taken together, these results suggest that the 60-kDa protein
may function as an agglutinating lectin and may recognize
and bind to carbohydrate structures present in the different
matrix glycoproteins.
DISCUSSION
In the study presented in this communication, we have
used Western ligand blotting to detect ligand-binding pro-
teins in S. aureus. A surprisingly large number of BSP-
binding proteins were detected in various S. aureus isolates.
The metabolic and structural relationships between these
proteins are presently unclear.
Strains Newman and #574 expressed major BSP-binding
proteins with apparent molecular masses of 60 and 72 kDa,
respectively. Both proteins were selectively solubilized by
extraction with 1 M LiCl and were purified by identical
purification protocols. Furthermore, preliminary peptide
mapping of these two proteins gave similar fragments (17a).
These data suggest that the 60-kDa protein of strain Newman
6 7
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FIG. 5. Effect of purified 60-kDa protein on the ability of S.
aureus #574 to bind 1MI-ligand. The indicated amount of 60-kDa
protein purified from strain Newman was mixed with 5 x 104 cpm of
various 125I-labeled ligands in an assay volume of 0.5 ml of ligand
binding buffer and incubated for 30 min on an end-over-end mixer at
room temperature. Bacterial cells (8 x 108) were added, and after 90
min of mixing at room temperature, unbound ligand was diluted by
the addition of 3 ml of ice-cold PBS containing 0.1% (vol/vol) Tween
80. After centrifugation at 1,350 x g for 20 min, the supernatant was
aspirated and the radioactivity associated with the bacterial pellet
was quantified with an LKB gamma counter. Results are expressed
as a percentage of the radioactivity bound by cells in the absence of
added protein (which was set to 100%). (A) O, BSP; *, FN; *,
29-kDa N-terminal FN fragment; A, collagen; 0, human fibrinogen.
(B) El, TSP; *, VN.
and the 72-kDa protein of strain #574 are closely related.
When strain #574 was grown in LB medium it bound more
251I-BSP and appeared to express more of the 72-kDa protein
than did cells grown in TSB. These observations suggest that
the 72-kDa protein mediates binding of BSP to S. aureus
cells.
The enhanced expression of the 72-kDa protein in LB-
grown cultures may be a consequence of the higher osmo-
larity of the medium. LB contains a twofold-higher concen-
tration of NaCl than does TSB. Whether osmolarity is the
environmental signal governing the expression of this pro-
tein has yet to be determined. It is also unclear whether the
expression of the 60- and 72-kDa proteins is regulated by the
accessory gene regulator (agr) (14).
TIhe 60- and 72-kDa proteins were released from bacteria
through extraction with 1 M LiCl, which suggests that they
are not firmly anchored in the cell wall or membrane but are
associated with the cell surface through an unknown mech-
anism. The LiCl extract contained only minor amounts of
other proteins, and purification of either protein was a
one-step procedure on a Mono-S column, owing to the
highly basic nature of these proteins. The purified protein
had a tendency to self-aggregate in solution, perhaps be-
cause of the high content of hydrophobic amino acids.
The potential role of the 60- and 72-kDa proteins as
general adhesins is demonstrated by their ability to bind a
number of extracellular matrix components. The molecular
bases for these interactions are unclear. The 60-kDa protein
appears to have a lectin-like activity, as demonstrated by the
ability of the purified protein to hemagglutinate SRBC in a
reaction sensitive to L-fucose, D-mannose, and melibiose.
Although the hemagglutination reaction is characteristic of
lectins, it has also been attributed to lipid moieties and highly
basic proteins (20). Our data indicate that the purified protein
is both highly basic and hydrophobic. Therefore, these
properties could explain the hemagglutination activity of the
protein. Further studies are obviously needed to define the
mechanism of matrix-protein interaction.
Neither the 60- nor the 72-kDa protein inhibited the
binding of radiolabeled ligands to bacterial cells when added
to incubation mixtures. Instead, a concentration-dependent
stimulation of bacterial binding of some ligands was ob-
served. This effect could be explained if the isolated protein,
perhaps through aggregation, acted as a multivalent ligand
binder. Large ligand-S. aureus protein aggregates could be
formed and subsequently could bind to the cells. Such a
mechanism would be facilitated if the ligands contained
several binding sites for the bacterial proteins.
The data presented describe cell surface proteins on S.
aureus cells which may act as general adhesins and bind a
number of extracellular matrix components. A general ad-
hesive mechanism has recently been suggested for Trepo-
nema denticola with respect to the binding of FN, laminin,
and FBG via two proteins with apparent molecular masses of
53 and 72 kDa (6). Furthermore, a surface protein related to
glyceraldehyde-3-phosphate-dehydrogenase and present on
Streptococcus pyogenes cells seems to have a broad ligand-
binding specificity (17, 23). The S. aureus proteins described
in this study may represent a similar binding mechanism and
could as such represent an important general virulence
determinant.
ACKNOWLEDGMENTS
This work was supported by NIH grants (AI20624 and HL47313),
the Swedish Medical Research Council, and a grant from Alfa-Laval
AB, Tumba, Sweden.
We thank Martin McGavin and Joseph Patti for many stimulating
discussions and Alice Morales for preparation of the manuscript.
REFERENCES
1. Chhatwal, G. S., K. T. Preissner, G. Muller-Berghaus, and H.
Blobel. 1987. Specific binding of the human S protein (vitronec-
tin) to streptococci, Staphylococcus aureus, and Eschenchia
coli. Infect. Immun. 55:1878-1883.
2. Engvail, E., and E. Rouslahti. 1977. Binding of soluble form of
INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
S. AUREUS EXTRACELLULAR MATRIX-BINDING PROTEIN
fibroblast surface protein, fibronectin, to collagen. Int. J. Can-
cer 20:1-5.
3. Franzen, A., and D. Heinegard. 1985. Isolation and character-
ization of two sialoproteins present only in bone calcified
matrix. Biochem. J. 232:715-724.
4. Froman, G., L. M. Switalski, P. Speziale, and M. Hook. 1987.
Isolation and characterization of a fibronectin receptor from
Staphylococcus aureus. J. Biol. Chem. 262:6564-6571.
5. Goldenberg, D. L., and J. I. Reed. 1985. Bacterial arthritis. N.
Engl. J. Med. 312:764-771.
6. Haapasalo, M., K.-H. Muller, V.-J. Uitto, W. Keung Leung, and
B. McBride. 1992. Characterization, cloning, and binding prop-
erties of the major 53-kDa Treponema denticola surface antigen.
Infect. Immun. 60:2058-2065.
7. Herrmann, M., S. J. Suchard, L. A. Boxer, F. A. Waldvogel, and
P. D. Lew. 1991. Thrombospondin binds to Staphylococcus
aureus and promotes staphylococcal adherence to surfaces.
Infect. Immun. 59:279-288.
8. Herrmann, M., P. E. Vaudaux, D. Pittet, R. Auckenthaler, P. D.
Lew, F. Schumacher-Perdreau, G. Peters, and F. A. Waldvogel.
1988. Fibronectin, fibrinogen and laminin act as mediators of
adherence of clinical staphylococcal isolates to foreign material.
J. Infect. Dis. 158:693-701.
9. Holderbaum, D., G. S. Hall, and L. A. Ehrhart. 1986. Collagen
binding to Staphylococcus aureus. Infect. Immun. 54:359-
364.
10. Hook, M., L. M. Switalski, T. Wadstrom, and M. Lindberg.
1989. Interaction of pathogenic microorganisms with fibronec-
tin, p. 295-308. In D. Mosher (ed.), Fibronectin. Academic
Press, Inc., New York.
11. Hunter, W. H. 1978. Radioimmunoassay, p. 14.1-14.40. In
D. M. Weir (ed.), Handbook of experimental immunology.
Blackwell Scientific Publications Ltd., Oxford.
12. Isberg, R. R. 1991. Discrimination between intracellular uptake
and surface adhesion of bacterial pathogens. Science 252:934-
938.
13. Jonsson, K., C. Signas, H.-P. Muller, and M. Lindberg. 1991.
Two different genes encode fibronectin binding proteins in
Staphylococcus aureus. Eur. J. Biochem. 202:1041-1048.
14. Kormblum, J., B. M. Kreiswirth, S. J. Projan, H. Ross, and
R. P. Novick. 1990. Agr: a polycistronic locus regulating exo-
protein synthesis in Staphylococcus aureus, p. 373-402. In
R. A. Skurray (ed.), Molecular biology of the staphylococci.
VCH Publishers Inc., New York.
15. Laemmli, U. K. 1970. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature (London)
227:680-685.
16. Lantz, M. S., L. M. Switalski, K. S. Kornman, and M. Hook.
1985. Bacteroides intermedius binds fibrinogen. J. Bacteriol.
163:623-628.
17. Lottenberg, R., C. C. Broder, M. D, P. Boyle, S. J. Kain, B. L.
Schroeder, and R. Curtiss. 1992. Cloning, sequence analysis,
and expression in Escherichia coli of a streptococcal plasmin
receptor. J. Bacteriol. 174:5204-5210.
17a.McGavin, M. H., and M. Ifok. Unpublished results.
18. McGavin, M. J., G. Raucci, S. Gurusiddappa, and M. Hook.
1991. Fibronectin binding determinants of the Staphylococ-
cus aureus fibronectin receptor. J. Biol. Chem. 266:8343-
8347.
19. Midura, R. J., D. J. McQuillan, K. J. Benham, L. W. Fisher, and
V. C. Hascall. 1990. A rat osteogenic cell line (UMR 106-01)
synthesizes a highly sulfated form of bone sialoprotein. J. Biol.
Chem. 265:5285-5291.
20. Mirelman, D., and I. Ofek. 1986. Introduction to microbial
lectins and agglutinins, p. 1-19. In D. Mirelman (ed.), Microbial
lectins and agglutinins: properties and biological activity. John
Wiley & Sons, Inc., New York.
21. Morrison, M., and G. S. Bayse. 1970. Catalysis of iodination by
lactoperoxidase. Biochemistry 9:2995-3000.
22. Murphy-Ullrich, J. E., and F. D. Mosher. 1985. Localization of
thrombospondin in clots formed in situ. Blood 66:1098-1104.
23. Pancholi, V., and V. A. Fischetti. 1992. A major surface protein
on group A streptococci is a glyceraldehyde-3-phosphate-dehy-
drogenase with multiple binding activity. J. Exp. Med. 176:415-
426.
24. Patti, J. M., H. Jonsson, B. Guss, L. M. Switalski, K. Wiberg,
M. Lindberg, and M. Hook. 1992. Molecular characterization
and expression of a gene encoding a Staphylococcus aureus
collagen adhesin. J. Biol. Chem. 267:4766-4772.
25. Pelletier, L., and R. G. Petersdorf. 1977. Infectious endocarditis:
a review of 125 cases from the University Washington Hospi-
tals. 1963-1972. Medicine 56:287-313.
26. Ramphal, R. 1990. The role of bacterial adhesion in cystic
fibrosis including the staphylococcal aspect. Infection 18:61-64.
27. Reese, C. A., and R. Mayne. 1981. Minor collagens of chicken
hyaline cartilage. Biochemistry 20:5443-5448.
28. Ryden, C. 1990. Osteomyelitis and staphylococcal adhesion, p.
69-75. In T. Wadstrom, I. Eliasson, I. Holder, and A. Ljungh
(ed.), Pathogenesis of wound and biomaterial-associated infec-
tions. Springer-Verlag, New York.
29. Ryden, C., I. Maxe, A. Franzen, A. Ljungh, D. Heinegard, and
K. Rubin. 1987. Selective binding of bone matrix sialoprotein to
Staphylococcus aureus in osteomyelitis. Lancet ii:515.
30. Ryden, C., A. I. Yacoub, I. Maxe, D. Heinegard, A. Oldberg, A.
Franzen, A. Ijungh, and K. Rubin. 1989. Specific binding of
bone sialoprotein to Staphylococcus aureus isolated from pa-
tients with osteomyelitis. Eur. J. Biochem. 184:331-336.
31. Signis, C., G. Raucci, K. Jonsson, P.-E. Lindgren, G. M.
Anantharamaiah, M. Hook, and M. Lindberg. 1989. Nucleotide
sequence of the gene for a fibronectin-binding protein from
Staphylococcus aureus: use of this peptide in the synthesis of
biologically active peptides. Proc. Natl. Acad. Sci. USA 86:
699-703.
32. Speziale, P., M. Hook, L. Switalsid, and T. Wadstrom. 1984.
Fibronectin binding to a Streptococcus pyogenes strain. J.
Bacteriol. 157:420-427.
33. Speziale, P., G. Raucci, L. Visai, L. Switalski, R. Timpl, and M.
Hook. 1986. Binding of collagen to Staphylococcus aureus
Cowan 1. J. Bacteriol. 167:77-81.
34. Switalski, L. M., J. M. Patti, W. Butcher, A. G. Gristina, P.
Speziale, and M. HooL A collagen receptor on Staphylococcus
aureus strains isolated from patients with septic arthritis medi-
ates adhesion to cartilage. Mol. Microbiol. 7:99-107.
35. Switalski, L. M., P. Speziale, and M. Hook. 1989. Isolation and
characterization of a putative collagen receptor from Staphylo-
coccus aureus strain Cowan 1. J. Biol. Chem. 264:21080-21086.
36. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic
transfer of proteins from polyacrylamide gels to nitrocellulose
sheets: procedure and some applications. Proc. Natl. Acad. Sci.
USA 76:4350-4354.
37. Waldvogel, F. A., and H. Vasev. 1980. Osteomyelitis: the past
decade. N. Engl. J. Med. 303:360-370.
VOL. 61, 1993 2485
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
